Role of the HBx oncoprotein in carbonic anhydrase 9 induction. 2010

Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Carbonic anhydrase 9 (CA9), as one of the most hypoxia-responsive genes, has been associated almost exclusively with hypoxic tumors. Its principal role is in pH regulation which helps tumor cells overcome intracellular acidosis and survive extended periods of time with low oxygen. Hypoxia-inducible factor 1 (HIF-1) is the main transcriptional activator of CA9. Hepatitis B virus X protein (HBx) has been shown to increase the transcriptional activity of HIF-1. HBx is often expressed from the gene integrated in the hepatocytes infected persistently and contributes significantly to alterations in host gene expression that can lead to the development of hepatocellular carcinoma (HCC) associated with Hepatitis B virus (HBV). The aim of this study was to determine the effect of HBx on expression of CA9. Transient transfection of HBx led to an increase in the expression of CA9 as assessed by RT-PCR and Western blotting. HBx was able to increase CA9 promoter activity significantly in several cell lines. The effect was mediated via HIF-1 and a functional HRE element located -10/-3 bp upstream of the CA9 transcription initiation site. These data suggest that CA9 may be involved in the development of HCC by contributing to the survival of hepatocytes infected with HBV in liver tissue with fibrosis.

UI MeSH Term Description Entries
D002256 Carbonic Anhydrases A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1. Carbonate Dehydratase,Carbonic Anhydrase,Anhydrases, Carbonic,Dehydratase, Carbonate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071231 Carbonic Anhydrase IX A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass transmembrane domain, and a short intracellular tail. It functions as a dimer and is expressed primarily by cells of the GASTROINTESTINAL TRACT; BILE DUCT EPITHELIUM; and GALL BLADDER. It is expressed at high levels in many solid tumors, especially CLEAR CELL RENAL CARCINOMA, in response to CELL HYPOXIA. CAIX Protein,Carbonic Anhydrase 9
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
June 2007, Cancer metastasis reviews,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
October 2017, Biochemical and biophysical research communications,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
June 1975, Doklady Akademii nauk SSSR,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
February 1975, The Journal of pharmacology and experimental therapeutics,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
January 1984, Annals of the New York Academy of Sciences,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
December 1952, Transactions of the New York Academy of Sciences,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
May 2021, Clinical science (London, England : 1979),
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
October 1958, Minerva anestesiologica,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
May 2021, International journal of molecular sciences,
Tereza Holotnakova, and Lucia Tylkova, and Martina Takacova, and Juraj Kopacek, and Juraj Petrik, and Silvia Pastorekova, and Jaromir Pastorek
January 2010, Current pharmaceutical design,
Copied contents to your clipboard!